Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Collegium Pharma (NQ: COLL ) 32.36 +0.32 (+1.00%) Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 119,712 Open 32.15 Bid (Size) 29.10 (2) Ask (Size) 34.21 (1) Prev. Close 32.04 Today's Range 31.90 - 32.49 52wk Range 20.83 - 40.95 Shares Outstanding 32,715,322 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Dr. Reddy's Labs Stock Sees Improved Technical Strength June 28, 2024 On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76. Via Investor's Business Daily 7 Biotech Stocks to Buy on the Dip: June 2024 June 24, 2024 With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. Via InvestorPlace Performance YTD +3.62% +3.62% 1 Month +0.28% +0.28% 3 Month -15.73% -15.73% 6 Month +3.62% +3.62% 1 Year +51.00% +51.00% More News Read More NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals. June 24, 2024 Via Chartmill Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise June 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews May 10, 2024 Via Benzinga Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know April 11, 2024 Via Benzinga Where Collegium Pharmaceutical Stands With Analysts February 23, 2024 Via Benzinga Collegium to Participate in Jefferies Global Healthcare Conference May 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $35 Million Accelerated Share Repurchase Program May 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Recap: Collegium Pharmaceutical Q4 Earnings February 22, 2024 Via Benzinga Analyst Expectations For Collegium Pharmaceutical's Future February 02, 2024 Via Benzinga Why Collegium Pharmaceutical Shares Are Gaining Today January 03, 2024 Via Benzinga Collegium Reports First Quarter 2024 Financial Results May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces CEO Transition May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER April 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 April 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026 April 11, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference April 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results February 22, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 February 08, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday January 03, 2024 Via Benzinga Topics Stocks Exposures US Equities Collegium Provides 2024 Financial Guidance January 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent November 27, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $25 Million Accelerated Share Repurchase Program November 09, 2023 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.